Literature DB >> 29757018

A current structural perspective on PXR and CAR in drug metabolism.

Cameron D Buchman1, Sergio C Chai1, Taosheng Chen1.   

Abstract

INTRODUCTION: Pregnane X receptor (PXR) and the constitutive androstane receptor (CAR) are two members of the nuclear receptor superfamily that play major roles in the expression of various drug metabolism enzymes and are known for their ligand promiscuity. As with other nuclear receptors, PXR and CAR are each composed of a ligand-binding domain (LBD) and a DNA-binding domain (DBD) connected by a hinge region. Areas covered: This review focuses on the information obtained over the last 15+ years from X-ray crystallography studies of the structure of PXR and CAR. Areas of focus include the mobility of each structure, based on temperature factors (B factors); multimeric interactions; the binding of coregulators and ligands; and how the crystal structures were obtained. The first use of hydrogen-deuterium exchange coupled with mass spectroscopy (HDX-MS) to study compound-protein interactions in the PXR-LBD is also addressed. Expert opinion: X-ray crystallography studies have provided us with an excellent understanding of how the LBDs of each receptor function; however, many questions remain concerning the structure of these receptors. Future research should focus on determining the co-crystal structure of an antagonist bound to PXR and on studying the structural aspects of the full-length CAR and PXR proteins.

Entities:  

Keywords:  Constitutive androstane receptor; HDX-MS; X-ray crystallography; pregnane X receptor; structural biology

Mesh:

Substances:

Year:  2018        PMID: 29757018      PMCID: PMC6002932          DOI: 10.1080/17425255.2018.1476488

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  71 in total

1.  The nuclear xenobiotic receptor CAR: structural determinants of constitutive activation and heterodimerization.

Authors:  Kelly Suino; Li Peng; Ross Reynolds; Yong Li; Ji-Young Cha; Joyce J Repa; Steven A Kliewer; H Eric Xu
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

2.  Structure of the murine constitutive androstane receptor complexed to androstenol: a molecular basis for inverse agonism.

Authors:  Li Shan; Jeremy Vincent; Joseph S Brunzelle; Isabelle Dussault; Min Lin; Irina Ianculescu; Mark A Sherman; Barry M Forman; Elias J Fernandez
Journal:  Mol Cell       Date:  2004-12-22       Impact factor: 17.970

3.  Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry.

Authors:  Lee Frego; Walter Davidson
Journal:  Protein Sci       Date:  2006-04       Impact factor: 6.725

Review 4.  Structural aspects of Vitamin D endocrinology.

Authors:  Natacha Rochel; Ferdinand Molnár
Journal:  Mol Cell Endocrinol       Date:  2017-02-28       Impact factor: 4.102

5.  Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability.

Authors:  Wenyan Wang; Winifred W Prosise; Jun Chen; S Shane Taremi; Hung V Le; Vincent Madison; Xiaoming Cui; Ann Thomas; K-C Cheng; Charles A Lesburg
Journal:  Protein Eng Des Sel       Date:  2008-05-02       Impact factor: 1.650

6.  A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity.

Authors:  Isabelle Dussault; Min Lin; Kevin Hollister; Ming Fan; John Termini; Mark A Sherman; Barry M Forman
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

7.  Deuterium exchange and mass spectrometry reveal the interaction differences of two synthetic modulators of RXRalpha LBD.

Authors:  Xuguang Yan; Efrén Pérez; Mark Leid; Michael I Schimerlik; Angel R de Lera; Max L Deinzer
Journal:  Protein Sci       Date:  2007-09-28       Impact factor: 6.725

8.  CINPA1 binds directly to constitutive androstane receptor and inhibits its activity.

Authors:  Milu T Cherian; Sergio C Chai; William C Wright; Aman Singh; Morgan Alexandra Casal; Jie Zheng; Jing Wu; Richard E Lee; Patrick R Griffin; Taosheng Chen
Journal:  Biochem Pharmacol       Date:  2018-03-31       Impact factor: 5.858

9.  Pharmacologic profile of the Adnectin BMS-962476, a small protein biologic alternative to PCSK9 antibodies for low-density lipoprotein lowering.

Authors:  Tracy Mitchell; Ginger Chao; Doree Sitkoff; Fred Lo; Hossain Monshizadegan; Daniel Meyers; Simon Low; Katie Russo; Rose DiBella; Fabienne Denhez; Mian Gao; Joseph Myers; Gerald Duke; Mark Witmer; Bowman Miao; Siew P Ho; Javed Khan; Rex A Parker
Journal:  J Pharmacol Exp Ther       Date:  2014-06-10       Impact factor: 4.030

10.  Active nuclear receptors exhibit highly correlated AF-2 domain motions.

Authors:  Denise G Teotico; Monica L Frazier; Feng Ding; Nikolay V Dokholyan; Brenda R S Temple; Matthew R Redinbo
Journal:  PLoS Comput Biol       Date:  2008-07-11       Impact factor: 4.475

View more
  15 in total

1.  Widespread epigenetic changes to the enhancer landscape of mouse liver induced by a specific xenobiotic agonist ligand of the nuclear receptor CAR.

Authors:  Andy Rampersaud; Nicholas J Lodato; Aram Shin; David J Waxman
Journal:  Toxicol Sci       Date:  2019-06-24       Impact factor: 4.849

2.  Efavirenz and Efavirenz-like Compounds Activate Human, Murine, and Macaque Hepatic IRE1α-XBP1.

Authors:  Carley J S Heck; Allyson N Hamlin; Namandjé N Bumpus
Journal:  Mol Pharmacol       Date:  2018-11-15       Impact factor: 4.436

3.  Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity.

Authors:  Zelalem Petros; Abiy Habtewold; Eyasu Makonnen; Eleni Aklillu
Journal:  Sci Rep       Date:  2022-06-11       Impact factor: 4.996

Review 4.  Strategies for developing pregnane X receptor antagonists: Implications from metabolism to cancer.

Authors:  Sergio C Chai; William C Wright; Taosheng Chen
Journal:  Med Res Rev       Date:  2019-11-28       Impact factor: 12.944

5.  Building a Chemical Toolbox for Human Pregnane X Receptor Research: Discovery of Agonists, Inverse Agonists, and Antagonists Among Analogs Based on the Unique Chemical Scaffold of SPA70.

Authors:  Yongtao Li; Wenwei Lin; William C Wright; Sergio C Chai; Jing Wu; Taosheng Chen
Journal:  J Med Chem       Date:  2021-01-26       Impact factor: 7.446

Review 6.  PXR-mediated idiosyncratic drug-induced liver injury: mechanistic insights and targeting approaches.

Authors:  Jingheng Wang; Monicah Bwayi; Rebecca R Florke Gee; Taosheng Chen
Journal:  Expert Opin Drug Metab Toxicol       Date:  2020-06-16       Impact factor: 4.481

7.  MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor.

Authors:  Jiaqi Li; Jing Zhao; Huan Wang; Xiaohan Li; Aixia Liu; Qin Qin; Boan Li
Journal:  Onco Targets Ther       Date:  2018-09-17       Impact factor: 4.147

8.  ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance.

Authors:  Xudong Gao; Hebing Chen; Xin Huang; Hao Li; Zhen Liu; Xiaochen Bo
Journal:  Onco Targets Ther       Date:  2019-02-26       Impact factor: 4.147

9.  Mutation of a single amino acid of pregnane X receptor switches an antagonist to agonist by altering AF-2 helix positioning.

Authors:  Andrew D Huber; William C Wright; Wenwei Lin; Kinjal Majumder; Jonathan A Low; Jing Wu; Cameron D Buchman; David J Pintel; Taosheng Chen
Journal:  Cell Mol Life Sci       Date:  2020-03-30       Impact factor: 9.261

Review 10.  Noncanonical Constitutive Androstane Receptor Signaling in Gene Regulation.

Authors:  Yuliya A Pustylnyak; Lyudmila F Gulyaeva; Vladimir O Pustylnyak
Journal:  Int J Mol Sci       Date:  2020-09-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.